Modulation of Innate Immunity by KSHV
Modulation of Innate Immunity by KSHV
批准号:
10421081
负责人:
BLOSSOM A DAMANIA
金额:
$41.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-11 至 2024-06-30
关键词:
Antiviral ResponseBindingCell Culture TechniquesCellsCyclic GMPDNADNA VirusesDevelopmentDinucleoside PhosphatesDiseaseGene ActivationGenesHIVHIV InfectionsHIV SeronegativityHumanHuman Herpesvirus 8ImmuneImmune responseImmune systemImmunosuppressionIn VitroIncidenceIndividualInfectionInnate Immune ResponseInterferonsKaposi SarcomaLifeLiquid substanceLymphomaMalignant NeoplasmsMediatingNatural ImmunityOralOral cavityPalate Kaposi&aposs SarcomaPathogenesisPathogenicityPathway interactionsPatientsPeriodicityPlayPopulationPrimary InfectionProductionProteinsReportingRoleRouteSalivaSexual TransmissionSignal TransductionStimulator of Interferon GenesSumSymptomsSyndromeTherapeutic immunosuppressionTimeToll-like receptorsTransplant RecipientsViralViral GenesViral GenomeViral PathogenesisViral ProteinsVirusVirus Inhibitorsantiretroviral therapybasecell typeco-infectionimmune reconstitutionin vivoinnate immune pathwaysmacrophagemicroorganismmonocytepreventreactivation from latencyreceptorrecombinant virusresponsesarcomasensorviral interferon regulatory factor-1
中文摘要
项目摘要
KSHV是人体内的一种共生致病微生物。
许多研究表明,KSHV存在于唾液和口腔中,并可
通过口头和性传播途径传播。在免疫的情况下
抑制,例如艾滋病毒感染或免疫抑制治疗,KSHV与
肉瘤和淋巴瘤的发展,包括在口腔内。虽然
这些疾病通常是在免疫抑制的背景下出现的,甚至是艾滋病毒-
阴性的人会患上与KSHV相关的癌症。因此,很明显,
宿主免疫系统在预防KSHV相关疾病中起着关键作用
感染。
目前尚不清楚免疫系统如何保持KSHV处于健康状态
个体,但允许疾病在免疫抑制时期发展。我们有
此前报道,TLR、RLR和NLR能够检测到KSHV在
不同生物相关细胞类型在初次感染期间和在
从延迟中重新激活。我们还报道了cGAS-STING DNA传感
途径可以检测到KSHV在初次感染和再激活过程中以及KSHV病毒
蛋白质可以抵消这一重要途径的激活。在此应用程序中,我们
建议确定KSHV病毒蛋白如何调节cGAS和先天刺痛
免疫蛋白并允许病毒在体内成功建立终生潜伏期
人类的主人。我们还建议研究KSHV对先天免疫的调节
途径影响艾滋病毒感染。
英文摘要
PROJECT ABSTRACT
KSHV is both a commensal and pathogenic microorganism in the human host.
Many studies have shown that KSHV is present in the saliva and oral cavity and can be
transmitted through both oral and sexual transmission routes. In conditions of immune
suppression e.g. HIV infection or immunosuppressive therapy, KSHV is associated with
the development of sarcomas and lymphomas, including in the oral cavity. Although
these diseases are usually seen in the context of immune suppression, even HIV-
negative individuals can develop KSHV-associated cancers. Thus, it is clear that the
host immune system plays a critical role in preventing diseases associated with KSHV
infection.
It is currently unclear how the immune system keeps KSHV in check in healthy
individuals, but allows disease to progress during times of immunosuppression. We have
previously reported that TLRs, RLRs and NLRs are capable of detecting KSHV in a
variety of different biologically relevant cell types during primary infection and during
reactivation from latency. We also reported that the cGAS-STING DNA sensing
pathway can detect KSHV during primary infection and reactivation and that KSHV viral
proteins can counteract activation of this important pathway. In this application, we
propose to determine how KSHV viral proteins modulate cGAS and STING innate
immune proteins and allow the virus to successfully establish life-long latency in the
human host. We also propose to examine how KSHV's modulation of innate immune
pathways impacts HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10434859
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Supplement: The Association Between Stigma and Wellbeing among Kaposi sarcoma and Lymphoma Patients in Malawi
-
批准号:10844951
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10084553
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10238156
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10906424
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10494459
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10652371
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Administrative Core
-
批准号:10679965
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2020
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mechanisms of KSHV Transmission
-
批准号:9896795
-
项目类别:
-
资助金额:$55.1万
-
财政年份:2019
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mechanisms of KSHV Transmission
-
批准号:9765479
-
项目类别:
-
资助金额:$52.73万
-
财政年份:2019
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mechanisms of KSHV Transmission
-
批准号:10133016
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2019
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mechanisms of KSHV Transmission
-
批准号:10598043
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2019
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mechanisms of KSHV Transmission
-
批准号:10398815
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2019
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Impact of HIV on the Tumor Microenvironment
-
批准号:10398014
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2018
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Modulation of Innate Immunity by KSHV
-
批准号:9620767
-
项目类别:
-
资助金额:$44.14万
-
财政年份:2018
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
2017 Viruses and Cells Gordon Research Conference and Gordon Research Seminar
-
批准号:9260410
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2017
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Analytics
-
批准号:8933171
-
项目类别:
-
资助金额:$5.46万
-
财政年份:2014
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Project 1
-
批准号:8933165
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2014
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Mentoring
-
批准号:8933170
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2014
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
Project 3
-
批准号:8933167
-
项目类别:
-
资助金额:$16.41万
-
财政年份:2014
-
负责人:BLOSSOM A DAMANIA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: